Acrivon Therapeutics Ownership 2024 | Who Owns Acrivon Therapeutics Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

100.00%

Insider Ownership

22.39%

Retail Ownership

-22.39%

Institutional Holders

38.00

Acrivon Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RA CAPITAL MANAGEMENT, L.P.	100.00%	1.38%	4,810,508	-	-	61,045,347,000	Mar 31, 2023
PERCEPTIVE ADVISORS LLC	72.97%	1.13%	3,007,858	-	-	38,169,718,000	Mar 31, 2023
SANDS CAPITAL VENTURES, LLC	40.09%	5.18%	1,652,605	-	-	20,971,557,000	Mar 31, 2023
CITADEL ADVISORS LLC	39.81%	0.00%	1,641,022	6,918	0.42%	20,148,346,000	Mar 31, 2023
WELLINGTON MANAGEMENT GROUP LLP	21.55%	0.00%	888,130	-12,019	-1.34%	11,137,595,000	Mar 31, 2023
FEDERATED HERMES, INC.	14.89%	0.02%	613,625	-209,675	-25.47%	7,786,901,000	Mar 31, 2023
MARSHALL WACE, LLP	14.49%	0.02%	597,469	-625,783	-51.16%	7,581,882,000	Mar 31, 2023
NEA MANAGEMENT COMPANY, LLC	11.69%	0.34%	481,677	-	-	4,889,985,000	Mar 31, 2023
BLACKROCK INC.	11.51%	0.00%	474,227	474,227	100.00%	6,017,940,000	Mar 31, 2023
VANGUARD GROUP INC	9.93%	0.00%	409,215	409,215	100.00%	5,192,938,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	4.26%	0.00%	175,404	175,404	100.00%	2,225,876,000	Mar 31, 2023
STATE STREET CORP	2.07%	0.00%	85,339	85,339	100.00%	1,082,952,000	Mar 31, 2023
NORTHERN TRUST CORP	1.69%	0.00%	69,751	69,751	100.00%	885,140,000	Mar 31, 2023
D. E. SHAW & CO., INC.	1.50%	0.00%	61,896	61,896	100.00%	785,460,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1.41%	0.00%	58,209	58,209	100.00%	738,672,000	Mar 31, 2023
DAFNA CAPITAL MANAGEMENT LLC	1.24%	0.19%	51,148	35,500	226.87%	649,068,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.78%	0.00%	32,262	32,262	100.00%	409,405,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	0.55%	0.00%	22,837	22,837	100.00%	289,801,000	Mar 31, 2023
BARCLAYS PLC	0.41%	0.00%	16,983	12,841	310.02%	215,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	0.33%	-	13,718	-25,082	-64.64%	174,081,000	Mar 31, 2023

Acrivon Therapeutics's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 100.00% of the company's total share outstanding, currently valued at $61.05B. The top 10 institutional shareholders own together 336.92% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SANDS CAPITAL VENTURES, LLC	40.09%	5.18%	1,652,605	-	-	20,971,557,000	Mar 31, 2023
RA CAPITAL MANAGEMENT, L.P.	100.00%	1.38%	4,810,508	-	-	61,045,347,000	Mar 31, 2023
PERCEPTIVE ADVISORS LLC	72.97%	1.13%	3,007,858	-	-	38,169,718,000	Mar 31, 2023
NEA MANAGEMENT COMPANY, LLC	11.69%	0.34%	481,677	-	-	4,889,985,000	Mar 31, 2023
DAFNA CAPITAL MANAGEMENT LLC	1.24%	0.19%	51,148	35,500	226.87%	649,068,000	Mar 31, 2023
FEDERATED HERMES, INC.	14.89%	0.02%	613,625	-209,675	-25.47%	7,786,901,000	Mar 31, 2023
MARSHALL WACE, LLP	14.49%	0.02%	597,469	-625,783	-51.16%	7,581,882,000	Mar 31, 2023
CITADEL ADVISORS LLC	39.81%	0.00%	1,641,022	6,918	0.42%	20,148,346,000	Mar 31, 2023
WELLINGTON MANAGEMENT GROUP LLP	21.55%	0.00%	888,130	-12,019	-1.34%	11,137,595,000	Mar 31, 2023
D. E. SHAW & CO., INC.	1.50%	0.00%	61,896	61,896	100.00%	785,460,000	Mar 31, 2023
METLIFE INVESTMENT MANAGEMENT, LLC	0.12%	0.00%	5,081	5,081	100.00%	64,477,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	1,092	933	586.79%	14,000	Mar 31, 2023
AMERITAS INVESTMENT PARTNERS, INC.	0.02%	0.00%	695	695	100.00%	8,820,000	Mar 31, 2023
AMERICAN INTERNATIONAL GROUP, INC.	0.10%	0.00%	4,178	4,178	100.00%	53,019,000	Mar 31, 2023
METROPOLITAN LIFE INSURANCE CO/NY	0.01%	0.00%	523	523	100.00%	6,637,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	4.26%	0.00%	175,404	175,404	100.00%	2,225,876,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1.41%	0.00%	58,209	58,209	100.00%	738,672,000	Mar 31, 2023
BLACKROCK INC.	11.51%	0.00%	474,227	474,227	100.00%	6,017,940,000	Mar 31, 2023
NORTHERN TRUST CORP	1.69%	0.00%	69,751	69,751	100.00%	885,140,000	Mar 31, 2023
VANGUARD GROUP INC	9.93%	0.00%	409,215	409,215	100.00%	5,192,938,000	Mar 31, 2023

The largest Acrivon Therapeutics shareholder by % of total assets is SANDS CAPITAL VENTURES, LLC. The company owns 1.65M shares of Acrivon Therapeutics (ACRV), representing 5.18% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	11.51%	0.00%	474,227	474,227	100.00%	6,017,940,000	Mar 31, 2023
VANGUARD GROUP INC	9.93%	0.00%	409,215	409,215	100.00%	5,192,938,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	4.26%	0.00%	175,404	175,404	100.00%	2,225,876,000	Mar 31, 2023
STATE STREET CORP	2.07%	0.00%	85,339	85,339	100.00%	1,082,952,000	Mar 31, 2023
NORTHERN TRUST CORP	1.69%	0.00%	69,751	69,751	100.00%	885,140,000	Mar 31, 2023
D. E. SHAW & CO., INC.	1.50%	0.00%	61,896	61,896	100.00%	785,460,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1.41%	0.00%	58,209	58,209	100.00%	738,672,000	Mar 31, 2023
DAFNA CAPITAL MANAGEMENT LLC	1.24%	0.19%	51,148	35,500	226.87%	649,068,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.78%	0.00%	32,262	32,262	100.00%	409,405,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	0.55%	0.00%	22,837	22,837	100.00%	289,801,000	Mar 31, 2023
BARCLAYS PLC	0.41%	0.00%	16,983	12,841	310.02%	215,000	Mar 31, 2023
CITADEL ADVISORS LLC	39.81%	0.00%	1,641,022	6,918	0.42%	20,148,346,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.16%	-	6,630	6,630	100.00%	84,000,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.14%	-	5,856	5,856	100.00%	74,313,000	Mar 31, 2023
DEUTSCHE BANK AG\	0.13%	-	5,369	5,369	100.00%	68,133,000	Mar 31, 2023
METLIFE INVESTMENT MANAGEMENT, LLC	0.12%	0.00%	5,081	5,081	100.00%	64,477,000	Mar 31, 2023
MORGAN STANLEY	0.14%	-	5,624	4,755	547.18%	71,368,000	Mar 31, 2023
AMERICAN INTERNATIONAL GROUP, INC.	0.10%	0.00%	4,178	4,178	100.00%	53,019,000	Mar 31, 2023
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	0.08%	0.00%	3,218	3,218	100.00%	40,836,000	Mar 31, 2023
NEW YORK STATE COMMON RETIREMENT FUND	0.05%	-	2,206	2,206	100.00%	28,000	Mar 31, 2023

As of Mar 31 2023, Acrivon Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 474.23K stocks of ACRV, valued at $6.02B.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MARSHALL WACE, LLP	14.49%	0.02%	597,469	-625,783	-51.16%	7,581,882,000	Mar 31, 2023
FEDERATED HERMES, INC.	14.89%	0.02%	613,625	-209,675	-25.47%	7,786,901,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	0.33%	-	13,718	-25,082	-64.64%	174,081,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-21,534	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-19,639	-100.00%	-	Mar 31, 2023
WELLINGTON MANAGEMENT GROUP LLP	21.55%	0.00%	888,130	-12,019	-1.34%	11,137,595,000	Mar 31, 2023
SANDS CAPITAL VENTURES, LLC	40.09%	5.18%	1,652,605	-	-	20,971,557,000	Mar 31, 2023
RA CAPITAL MANAGEMENT, L.P.	100.00%	1.38%	4,810,508	-	-	61,045,347,000	Mar 31, 2023
PERCEPTIVE ADVISORS LLC	72.97%	1.13%	3,007,858	-	-	38,169,718,000	Mar 31, 2023
NEA MANAGEMENT COMPANY, LLC	11.69%	0.34%	481,677	-	-	4,889,985,000	Mar 31, 2023
FMR LLC	0.00%	-	122	122	100.00%	1,548,000	Mar 31, 2023
CITIGROUP INC	0.00%	-	202	202	100.00%	2,563,000	Mar 31, 2023
METROPOLITAN LIFE INSURANCE CO/NY	0.01%	0.00%	523	523	100.00%	6,637,000	Mar 31, 2023
UBS GROUP AG	0.13%	-	5,396	648	13.65%	68,475,000	Mar 31, 2023
ROYAL BANK OF CANADA	0.02%	-	665	665	100.00%	8,000,000	Mar 31, 2023
AMERITAS INVESTMENT PARTNERS, INC.	0.02%	0.00%	695	695	100.00%	8,820,000	Mar 31, 2023
LEGAL & GENERAL GROUP PLC	0.02%	-	924	924	100.00%	11,726,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	1,092	933	586.79%	14,000	Mar 31, 2023
AMALGAMATED BANK	0.03%	0.00%	1,130	1,130	100.00%	14,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.04%	-	1,588	1,588	100.00%	20,152,000	Mar 31, 2023

As of Mar 31 2023, Acrivon Therapeutics's biggest institutional seller is MARSHALL WACE, LLP. The company sold -0.63M shares of ACRV, valued at $7.58B.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	11.51%	0.00%	474,227	474,227	100.00%	6,017,940,000	Mar 31, 2023
VANGUARD GROUP INC	9.93%	0.00%	409,215	409,215	100.00%	5,192,938,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	4.26%	0.00%	175,404	175,404	100.00%	2,225,876,000	Mar 31, 2023
STATE STREET CORP	2.07%	0.00%	85,339	85,339	100.00%	1,082,952,000	Mar 31, 2023
NORTHERN TRUST CORP	1.69%	0.00%	69,751	69,751	100.00%	885,140,000	Mar 31, 2023
D. E. SHAW & CO., INC.	1.50%	0.00%	61,896	61,896	100.00%	785,460,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1.41%	0.00%	58,209	58,209	100.00%	738,672,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.78%	0.00%	32,262	32,262	100.00%	409,405,000	Mar 31, 2023
BANK OF NEW YORK MELLON CORP	0.55%	0.00%	22,837	22,837	100.00%	289,801,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.16%	-	6,630	6,630	100.00%	84,000,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.14%	-	5,856	5,856	100.00%	74,313,000	Mar 31, 2023
DEUTSCHE BANK AG\	0.13%	-	5,369	5,369	100.00%	68,133,000	Mar 31, 2023
METLIFE INVESTMENT MANAGEMENT, LLC	0.12%	0.00%	5,081	5,081	100.00%	64,477,000	Mar 31, 2023
AMERICAN INTERNATIONAL GROUP, INC.	0.10%	0.00%	4,178	4,178	100.00%	53,019,000	Mar 31, 2023
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	0.08%	0.00%	3,218	3,218	100.00%	40,836,000	Mar 31, 2023
NEW YORK STATE COMMON RETIREMENT FUND	0.05%	-	2,206	2,206	100.00%	28,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.04%	-	1,588	1,588	100.00%	20,152,000	Mar 31, 2023
AMALGAMATED BANK	0.03%	0.00%	1,130	1,130	100.00%	14,000	Mar 31, 2023
LEGAL & GENERAL GROUP PLC	0.02%	-	924	924	100.00%	11,726,000	Mar 31, 2023
AMERITAS INVESTMENT PARTNERS, INC.	0.02%	0.00%	695	695	100.00%	8,820,000	Mar 31, 2023
ROYAL BANK OF CANADA	0.02%	-	665	665	100.00%	8,000,000	Mar 31, 2023
METROPOLITAN LIFE INSURANCE CO/NY	0.01%	0.00%	523	523	100.00%	6,637,000	Mar 31, 2023
CITIGROUP INC	0.00%	-	202	202	100.00%	2,563,000	Mar 31, 2023
FMR LLC	0.00%	-	122	122	100.00%	1,548,000	Mar 31, 2023

Acrivon Therapeutics's largest new institutional shareholder by number of shares is BLACKROCK INC., purchased 474.23K shares, valued at $6.02B, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA INVESTMENTS, LP	-	-	-	-21,534	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-19,639	-100.00%	-	Mar 31, 2023

Acrivon Therapeutics's largest sold out institutional shareholder by shares sold is TWO SIGMA INVESTMENTS, LP, sold -21.53K shares, valued at -, as of undefined.

Acrivon Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.02%	58,000	26,200	82.39%	Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS	0.01%	6,200	-	-	Mar 31, 2024
Federated Hermes Equity Funds	0.01%	184,378	-35,432	-16.12%	Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.00%	16,624	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.00%	1,307	-	-	Mar 31, 2024
FEDERATED HERMES INSURANCE SERIES	0.00%	6,565	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	430,199	-99,887	-18.84%	Mar 31, 2024
ETF Series Solutions	0.00%	15,634	2,504	19.07%	Feb 29, 2024
SCHWAB CAPITAL TRUST	0.00%	23,041	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	96,782	-385	-0.40%	Feb 29, 2024
Calvert Variable Products, Inc.	0.00%	695	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	6,404	-	-	Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	3,389	-	-	Mar 31, 2024
Global X Funds	0.00%	3,889	-	-	Jan 31, 2024
SCHWAB STRATEGIC TRUST	0.00%	46,774	1,566	3.46%	Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC	0.00%	376	-	-	Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	3,100	-	-	Mar 31, 2024
T. Rowe Price Index Trust, Inc.	0.00%	832	443	113.88%	Mar 31, 2024
NORTHERN FUNDS	0.00%	4,164	283	7.29%	Mar 28, 2024
ALLSPRING MASTER TRUST	0.00%	1,564	-	-	Feb 29, 2024
iSHARES TRUST	0.00%	395,247	71,596	22.12%	Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	38,061	4,825	14.52%	Feb 29, 2024
RYDEX SERIES FUNDS	0.00%	79	-	-	Dec 31, 2023
EQ ADVISORS TRUST	0.00%	18,322	471	2.64%	Mar 31, 2024
PENN SERIES FUNDS INC	0.00%	400	-	-	Mar 28, 2024
VALIC Co I	0.00%	3,336	-13	-0.39%	Feb 29, 2024
RYDEX DYNAMIC FUNDS	0.00%	39	-	-	Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	1,227	-	-	Mar 31, 2024
ProFunds	0.00%	95	23	31.94%	Mar 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	903	-25	-2.69%	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,252	-	-	Jan 31, 2024
PROSHARES TRUST	0.00%	1,273	154	13.76%	Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	468	-	-	Feb 29, 2024
RYDEX VARIABLE TRUST	0.00%	5	-	-	Dec 31, 2023
TIAA-CREF FUNDS	0.00%	11,821	-	-	Jan 31, 2024
Brighthouse Funds Trust II	0.00%	3,260	-	-	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	7,400	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	985	-4	-0.40%	Jan 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	8,674	2,137	32.69%	Mar 31, 2024
AMERICAN CENTURY ETF TRUST	0.00%	177	-	-	Feb 29, 2024
PACIFIC SELECT FUND	0.00%	4,819	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,127	2,127	-	Mar 31, 2024
Bridge Builder Trust	0.00%	3,442	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	1,049	-	-	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	1,208	-	-	Jan 31, 2024
BLACKROCK FUNDS	0.00%	791	-	-	Jan 31, 2024

Acrivon Therapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 58.00K shares, compromising 0.02% of its total assets.

Acrivon Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	38	111.11%
31 Dec, 22	18	-

As of 31 Mar 23, 38 institutions are holding Acrivon Therapeutics's shares, representing an increase of 111.11% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	15,214,382	1.66%
31 Dec, 22	14,965,637	-

Acrivon Therapeutics (ACRV) has 15.21M shares outstanding as of 31 Mar 23, up 1.66% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	100.00%	-
31 Dec, 22	100.00%	-

As of 31 Mar 23, Acrivon Therapeutics is held by 100.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	6	-
31 Dec, 22	-	-

6 institutional shareholders have increased their position in ACRV stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	4	-
31 Dec, 22	-	-

4 institutional shareholders have reduced their position in ACRV stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	38	111.11%	15,214,382	1.66%	100.00%	-	6	-	4	-
31 Dec, 22	18	-	14,965,637	-	100.00%	-	-	-	-	-

Acrivon Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 16, 2024	Peterson Katharine	officer	Chief Accounting Officer	F-InKind	Sell	99	$7.02	$694.98	4,634
Aug 16, 2024	Miller Mary	officer	Chief Legal Officer	F-InKind	Sell	184	$7.02	$1.29K	38,967
Aug 16, 2024	Masson Kristina	director, officer	EVP - Business Operations	F-InKind	Sell	490	$7.02	$3.44K	317,246
Aug 16, 2024	Holm-Jorgensen Rasmus	officer	Chief Financial Officer	F-InKind	Sell	368	$7.02	$2.58K	26,890
Aug 16, 2024	Gamelin Erick	officer	Chief Development Officer	F-InKind	Sell	402	$7.02	$2.82K	17,363
Aug 16, 2024	Devroe Eric	officer	Chief Operating Officer	F-InKind	Sell	613	$7.02	$4.30K	68,484
Aug 16, 2024	Blume-Jensen Peter	director, officer	President and CEO	F-InKind	Sell	59,765	$7.02	$419.55K	2,502,129
Jul 19, 2024	Miller Mary	officer	Chief Legal Officer	F-InKind	Sell	558	$7.69	$4.29K	39,151
May 21, 2024	Devroe Eric	officer	Chief Operating Officer	M-Exempt	Sell	10,000	$1.04	$10.40K	86,615
May 16, 2024	Peterson Katharine	officer	Chief Accounting Officer	F-InKind	Sell	99	$8.36	$827.64	4,733
May 16, 2024	Miller Mary	officer	Chief Legal Officer	F-InKind	Sell	184	$8.36	$1.54K	39,709
May 16, 2024	Masson Kristina	director, officer	EVP - Business Operations	F-InKind	Sell	490	$8.36	$4.10K	317,736
May 16, 2024	Holm-Jorgensen Rasmus	officer	Chief Financial Officer	F-InKind	Sell	368	$8.36	$3.08K	27,258
May 16, 2024	Gamelin Erick	officer	Chief Development Officer	F-InKind	Sell	402	$8.36	$3.36K	17,765

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 16, 2024	Peterson Katharine	officer	Chief Accounting Officer	F-InKind	Sell	99	$7.02	$694.98	4,634
Aug 16, 2024	Miller Mary	officer	Chief Legal Officer	F-InKind	Sell	184	$7.02	$1.29K	38,967
Aug 16, 2024	Masson Kristina	director, officer	EVP - Business Operations	F-InKind	Sell	490	$7.02	$3.44K	317,246
Aug 16, 2024	Holm-Jorgensen Rasmus	officer	Chief Financial Officer	F-InKind	Sell	368	$7.02	$2.58K	26,890
Aug 16, 2024	Gamelin Erick	officer	Chief Development Officer	F-InKind	Sell	402	$7.02	$2.82K	17,363
Aug 16, 2024	Devroe Eric	officer	Chief Operating Officer	F-InKind	Sell	613	$7.02	$4.30K	68,484
Aug 16, 2024	Blume-Jensen Peter	director, officer	President and CEO	F-InKind	Sell	59,765	$7.02	$419.55K	2,502,129
Jul 19, 2024	Miller Mary	officer	Chief Legal Officer	F-InKind	Sell	558	$7.69	$4.29K	39,151
Jun 24, 2024	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner		A-Award	Buy	20,275	$6.52	$132.19K	20,275
Jun 24, 2024	TOMSICEK MICHAEL JOHN	director	-	A-Award	Buy	20,275	$6.52	$132.19K	20,275
Jun 24, 2024	Shacham Sharon	director	-	A-Award	Buy	20,275	$6.52	$132.19K	20,275
Jun 24, 2024	DiRocco Derek	director	-	A-Award	Buy	20,275	$6.52	$132.19K	20,275
Jun 24, 2024	BAUM CHARLES M	director	-	A-Award	Buy	20,275	$6.52	$132.19K	20,275
May 21, 2024	Devroe Eric	officer	Chief Operating Officer	M-Exempt	Sell	10,000	$1.04	$10.40K	86,615
May 21, 2024	Devroe Eric	officer	Chief Operating Officer	M-Exempt	Buy	10,000	$1.04	$10.40K	69,097
May 16, 2024	Peterson Katharine	officer	Chief Accounting Officer	F-InKind	Sell	99	$8.36	$827.64	4,733
May 16, 2024	Miller Mary	officer	Chief Legal Officer	F-InKind	Sell	184	$8.36	$1.54K	39,709
May 16, 2024	Masson Kristina	director, officer	EVP - Business Operations	F-InKind	Sell	490	$8.36	$4.10K	317,736
May 16, 2024	Holm-Jorgensen Rasmus	officer	Chief Financial Officer	F-InKind	Sell	368	$8.36	$3.08K	27,258
May 16, 2024	Gamelin Erick	officer	Chief Development Officer	F-InKind	Sell	402	$8.36	$3.36K	17,765

The last insider sell of Acrivon Therapeutics's stock was made by Peterson Katharine on Aug 16 2024, selling 99 shares at $7.02 per share (valued at $694.98).

Acrivon Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	8	-
Q2 2024	8	13	61.54%
Q1 2024	3	7	42.86%
Q4 2023	-	7	-
Q3 2023	3	2	150.00%
Q2 2023	4	8	50.00%
Q4 2022	12	7	171.43%

0 total buy trades, and 8 total sell trades (buy/sell ratio of 0.00%) were made by Acrivon Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	1	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	5	-
Q4 2022	2	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Acrivon Therapeutics's stocks.

Acrivon Therapeutics Peer Ownership

Ticker	Company
ANAB	AnaptysBio, Inc.
PMVP	PMV Pharmaceuticals, Inc.
MLYS	Mineralys Therapeutics, Inc.
AVTE	Aerovate Therapeutics, Inc.
ANTX	AN2 Therapeutics, Inc.
RZLT	Rezolute, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
ADAG	Adagene Inc.
MOLN	Molecular Partners AG
OPT	Opthea Limited

ACRV Ownership FAQ

Who Owns Acrivon Therapeutics?

Acrivon Therapeutics is owned by institutional shareholders (100.00%), insiders (22.39%), and public (-22.39%). The largest institutional shareholder of Acrivon Therapeutics is RA CAPITAL MANAGEMENT, L.P. (100.00% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.02% of total shares).

Who are the major institutional shareholders of Acrivon Therapeutics?

Acrivon Therapeutics's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, SANDS CAPITAL VENTURES, LLC, CITADEL ADVISORS LLC, and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 274.42% of the company's share outstanding.

How many Acrivon Therapeutics shareholders are there?

As of Mar 2023, there are 38 institutional shareholders of Acrivon Therapeutics.

What percentage of Acrivon Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?

RA CAPITAL MANAGEMENT, L.P owns 4.81M shares of Acrivon Therapeutics, representing 100.00% of the company's total shares outstanding, valued at $61.05B (as of Mar 2023).

What percentage of Acrivon Therapeutics is owned by PERCEPTIVE ADVISORS LLC?

As of Mar 2023, PERCEPTIVE ADVISORS LLC holds 3.01M shares of Acrivon Therapeutics (ACRV), compromising 72.97% of the company, valued at $38.17B.

What percentage of Acrivon Therapeutics is owned by SANDS CAPITAL VENTURES, LLC?

SANDS CAPITAL VENTURES, LLC is the third largest holder of Acrivon Therapeutics. The company owns 1.65M of the company's shares outstanding (worth $20.97B).